Search

everythinglearnresearchcommunity

for

Search:↓

More than half of the young women checked had PCOS, which was linked to inactive lifestyles and poor diets.

Fenugreek seed extract safely reduces ovarian volume and cyst size in women with PCOS.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

The study concluded that personalized treatment, including medical and cosmetic approaches, is effective for women with PCOS and hirsutism.

Spearmint tea may reduce testosterone and self-reported hair growth in women with PCOS.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Metformin can cause hair loss in some women with PCOS.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.